Becker's Healthcare August 1, 2024
Rylee Wilson

Cigna is planning to vigorously defend its pharmacy benefit manager from scrutiny.

On an Aug. 1 call with investors, Cigna Group CEO David Cordani said the company will be more aggressive in communicating the value of its PBM to lawmakers, customers and the public.

“We challenge ourselves to be much more aggressive and complete relative to communication and engagement in support of our clients, be they employers or health plan customers, collaborating even more deeply and intensely with independent pharmacies … and working on the Hill, of course,” Mr. Cordani said.

Mr. Cordani’s comments come as PBMs are under intense scrutiny in Washington. In July, a Federal Trade Commission report alleged PBMs show favoritism toward their own...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Centene expands board with former Prudential finance chief
Revenue Cycle and Payer News – February 26, 2025
Humana Taps Thyme Care for Value-Based Oncology Care
Trump's new price transparency executive order: 6 notes for payers
Most doctors fear insurers using AI to deny coverage

Share This Article